Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Just Wondering

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on May 21, 2024 6:20pm

69 Views

Post# 36050915

RE:RE:RE:RE:RE:Just Wondering

Haha don't let it get to you sweety. I can do this all day. You have many volumes of nonsense built up in your archive and I, for everyone's viewing pleasure, will continue to pore through it.

Best predictor of future stupidity is past stupidity.

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch